1st Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$250,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

HR 8, Fiscal Cliff Bill, Diabetic Testing Supplies Provisions; S.644, The Preventing Abuse of Cough Treatments Act of 2013; HR 1285, Making Hydrocodne Schedule II; S. 621, THe Safe Prescribing Act of 2013; HR 1024, The Medication Therapy Management Empowerment Act of 2013; S. 557, The Medication Therapy Management Empowerment Act of 2013; HR 1188, The Preserving our Hometown Independent Pharmacies Act of 2013 SEE ADDENDUMPharmaceutical Supply Chain Security Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in the National Defense Authorization Act; Deficit Reduction Issues; Pharmacy Preferred Networks issues

LobbyistCovered position, as disclosed
JOHN M COSTER —
KARRY LA VIOLETTE New —
DAVID SANDERS —
MICHAEL TOMBERLIN —

Contacted: HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); SENATE; Government Accountability Office (GAO); Defense, Dept of (DOD); Food & Drug Administration (FDA); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA)

Bills named: S. 644 (113th), H.R. 1188 (113th), H.R. 1285 (113th), S. 557 (113th), S. 621 (113th), H.R. 1024 (113th), H.R. 8 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.